InvestorsHub Logo
Followers 22
Posts 4029
Boards Moderated 0
Alias Born 10/12/2013

Re: ranjo post# 102689

Thursday, 03/16/2017 8:04:55 PM

Thursday, March 16, 2017 8:04:55 PM

Post# of 429246

no matter how robust the numbers are there will be hit pieces written by some highly respected cardiologist who will cast doubt on the results; the inert placebo or the credibility of some location that had more favorable results -its all part of the game we play. They can magnify a sub part that seemingly shows no statistical significance comparing vascepa to otc fish oil, etc. If reduce it is moderately successful say anything close to 20% they won't find a safer add on to statin which is our game changer. Matter of fact it may mitigate the muscle soreness or any other adverse effect enabling those who can't tolerate statins to now be able to benefit from a vascepa combo. I've been long since early 10' and added a while back so I expect a higher RRR than I mentioned.




If you are trying to pick a fight, ya ain't gonna get anywhere. I'm pretty much in 1:1 agreement with you. You'll have to go with politics or religion... (That's humor, for the overly emotional and trigger happy out there)

This morning I blew out my position in ACAD to scale up the position in AMRN. I'll work back into ACAD, but I have time there and if AMRN starts to ramp up, I want to be there....

Tick... Tick... Tick
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News